tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Takeda presents interim data from Phase 1b study of mezagitamab
PremiumThe FlyTakeda presents interim data from Phase 1b study of mezagitamab
14d ago
Takeda’s Earnings Call: Mixed Outlook Amid Challenges
Premium
Company Announcements
Takeda’s Earnings Call: Mixed Outlook Amid Challenges
18d ago
Takeda completes seven-year Phase 3 TIDES trial of Qdenga
Premium
The Fly
Takeda completes seven-year Phase 3 TIDES trial of Qdenga
19d ago
Sector Spotlight: UnitedHealth shareholder proposes split of CEO, chair role
PremiumThe FlySector Spotlight: UnitedHealth shareholder proposes split of CEO, chair role
2M ago
Nike reports Q1 beat, U.S. takes 5% stake in Lithium Americas: Morning Buzz
Premium
The Fly
Nike reports Q1 beat, U.S. takes 5% stake in Lithium Americas: Morning Buzz
2M ago
Takeda to discontinue cell therapy efforts
Premium
The Fly
Takeda to discontinue cell therapy efforts
2M ago
Alkermes price target lowered to $43 from $45 at Needham
PremiumThe FlyAlkermes price target lowered to $43 from $45 at Needham
2M ago
Harmony Biosciences price target lowered to $48 from $49 at Needham
Premium
The Fly
Harmony Biosciences price target lowered to $48 from $49 at Needham
2M ago
Alkermes price target raised to $35 from $34 at JPMorgan
Premium
The Fly
Alkermes price target raised to $35 from $34 at JPMorgan
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100